Nuri İhSan Kalyoncu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nuri İhSan Kalyoncu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Mine Kadioglu
Karadeniz Technical University, Teratology Information Service of Teratogenicity Research and Application Center, Trabzon, TURKEY
11 shared publications - Ersin Yaris
Karadeniz Technical University, Teratology Information Service of Teratogenicity Research and Application Center, Trabzon, TURKEY
10 shared publications - Ilknur Erkoseoglu
Faculty of Medicine, Department of Pharmacology Karadeniz Technical University Trabzon Turkiye
8 shared publications Murat Kesim
Karadeniz Technical University Teratology Information Service, Trabzon, Turkey
6 shared publications- Engin Yenilmez
Karadeniz Teknik Üniversitesi
5 shared publications - Mehmet Armagan Osmanagaoglu
Faculty of Medicine, Department of Perinatology, Karadeniz Technical University, Trabzon, Turkey
5 shared publications
Latest Publications
- Open Access
- 26 December 2025
- Published by Amasya University in Sabuncuoglu Serefeddin Health Sciences
- Vol. 7 (3) , 176-187
EXAMINATION OF THE EFFECTS OF EPIGALLOCATECHIN GALLATE IN EXPERIMENTAL DEPRESSION MODEL OF MICE
Depression has a prevalence of approximately 5%. The pathophysiology of depression is reported to involve monoamine deficiency, elevated cortisol levels, Brain-Derived Neurotrophic Factor (BDNF) deficiency, increased glutamate, and inflammation. To date, no effective treatment protocol has been developed for cortisol elevation and inflammatory factors, which are proposed to play a role in the pathophysiology of depression. Epigallocatechin gallate (EGCG) is a flavonoid derivative that occurs naturally in green tea. Numerous studies have shown that the substance possesses both antiinflammatory and antioxidant properties. It has also been demonstrated to possess anxiolytic properties. The present study was conducted to investigate the potential antidepressant effect of EGCG through anti-inflammatory mechanisms. To this end, the mice were divided into seven groups (n=10) and the "Porsolt's forced swimming test" was administered to compare the effects of EGCG with those of classic antidepressant drugs (paroxetine, venlafaxine, moclobemide). Furthermore, cortisol and IL-6 levels were measured in mice before and after treatment with the effective EGCG dose (100 mg kg⁻¹). In contrast to the effects observed with conventional antidepressants, EGCG doses of 25 mg kg⁻¹ and 50 mg kg⁻¹ did not demonstrate a significant impact, while the 100 mg/kg dose exhibited a substantial antidepressant effect. A subsequent comparison of corticosterone levels between the control and EGCG 100 mg/kg groups (9387.7 pg mL⁻¹ and 6147.0 pg mL⁻¹ respectively) revealed a significant (p
- 26 December 2025
- Published by Amasya University in Sabuncuoglu Serefeddin Health Sciences
- Vol. 7 (3) , 176-187
Open AccessEXAMINATION OF THE EFFECTS OF EPIGALLOCATECHIN GALLATE IN EXPERIMENTAL DEPRESSION MODEL OF MICE
Depression has a prevalence of approximately 5%. The pathophysiology of depression is reported to involve monoamine deficiency, elevated cortisol levels, Brain-Derived Neurotrophic Factor (BDNF) deficiency, increased glutamate, and inflammation. To date, no effective treatment protocol has been developed for cortisol elevation and inflammatory factors, which are proposed to play a role in the pathophysiology of depression. Epigallocatechin gallate (EGCG) is a flavonoid derivative that occurs naturally in green tea. Numerous studies have shown that the substance possesses both antiinflammatory and antioxidant properties. It has also been demonstrated to possess anxiolytic properties. The present study was conducted to investigate the potential antidepressant effect of EGCG through anti-inflammatory mechanisms. To this end, the mice were divided into seven groups (n=10) and the "Porsolt's forced swimming test" was administered to compare the effects of EGCG with those of classic antidepressant drugs (paroxetine, venlafaxine, moclobemide). Furthermore, cortisol and IL-6 levels were measured in mice before and after treatment with the effective EGCG dose (100 mg kg⁻¹). In contrast to the effects observed with conventional antidepressants, EGCG doses of 25 mg kg⁻¹ and 50 mg kg⁻¹ did not demonstrate a significant impact, while the 100 mg/kg dose exhibited a substantial antidepressant effect. A subsequent comparison of corticosterone levels between the control and EGCG 100 mg/kg groups (9387.7 pg mL⁻¹ and 6147.0 pg mL⁻¹ respectively) revealed a significant (p
- Open Access
- 22 December 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (4) , 955-963
Effects of cyproterone acetate treatment interruption on testicular histology: an experimental rat study relevant to transgender females with incomplete sperm cryopreservation
Purpose: The aim of this study was to investigate the reversibility of the deterioration of testicles as Cyproterone acetate (CPA) treatment ceased in an experimental rat model, and possible contribution of two angiotensin converting enzyme inhibitors on the process.Materials and Methods: In the first step, the effects of CPA treatment (14 days) on testicular histology on rats were investigated. In the second step, following the treatment period of 14 days with CPA, the effects of captopril or lisinopril application (for three days or seven days or 14 days) were investigated. Sixty-six rats in eleven groups were investigated. The testicles of the rats were planned to be examined on the following day of the last treatment schedule. Right testicular weight values were recorded. Testicles were histologically evaluated based on light microscopical findings, and also a scoring system was used.Results: CPA treatment caused weight loss of the testicles, and caused histological scoring value changes. The second step findings revealed that the weight values of the testicles returned to control values in the third day and thereafter. Also, histological scoring values were indifferent compared to control, statistically. Histopathological findings, noted, besides scoring, showed that edema, present in all rats in the seventh day in physiological serum treatment group, was not the case for captopril groups. Also, in captopril groups, no rat with germ cell depletion was observed.Conclusion: We conclude that the changes in testicular histology were over in the third day in our rat population, and inflammatory reactions or a delay in recovery may be prevented by use of angiotensin converting enzyme inhibitors, especially a thiol-group containing agent, captopril.
- 22 December 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (4) , 955-963
Open AccessEffects of cyproterone acetate treatment interruption on testicular histology: an experimental rat study relevant to transgender females with incomplete sperm cryopreservation
Purpose: The aim of this study was to investigate the reversibility of the deterioration of testicles as Cyproterone acetate (CPA) treatment ceased in an experimental rat model, and possible contribution of two angiotensin converting enzyme inhibitors on the process.Materials and Methods: In the first step, the effects of CPA treatment (14 days) on testicular histology on rats were investigated. In the second step, following the treatment period of 14 days with CPA, the effects of captopril or lisinopril application (for three days or seven days or 14 days) were investigated. Sixty-six rats in eleven groups were investigated. The testicles of the rats were planned to be examined on the following day of the last treatment schedule. Right testicular weight values were recorded. Testicles were histologically evaluated based on light microscopical findings, and also a scoring system was used.Results: CPA treatment caused weight loss of the testicles, and caused histological scoring value changes. The second step findings revealed that the weight values of the testicles returned to control values in the third day and thereafter. Also, histological scoring values were indifferent compared to control, statistically. Histopathological findings, noted, besides scoring, showed that edema, present in all rats in the seventh day in physiological serum treatment group, was not the case for captopril groups. Also, in captopril groups, no rat with germ cell depletion was observed.Conclusion: We conclude that the changes in testicular histology were over in the third day in our rat population, and inflammatory reactions or a delay in recovery may be prevented by use of angiotensin converting enzyme inhibitors, especially a thiol-group containing agent, captopril.
- Open Access
- 24 June 2024
- Published by Springer Nature in Research Square
Effects of Atorvastatin and Gemfibrozil on Mice Corpus Cavernosum, in vitro
Most of the drugs used in the treatment of cardiovascular diseases cause unfavourable effects on erectile functions. In this study, the effect of atorvastatin and gemfibrozil, which has different hypolipidemic mechanisms of action, on the erectile functions observed in mouse corpus cavernosum tissues are evaluatedin vitro. Mouse corpus cavernosum tissues are dissected under ketamine and xylazine anesthesia. Vessels were suspended in 30 ml organ baths filled with Krebs solution and aerated with carbogen (95% O2, 5% CO2) at 37°C. A initial tension of 500 mg was applied to the suspended tissue strips. After a stabilisation period of 90 minutes, the protocols were applied to the tissue. Atorvastatin and gemfibrozil showed no direct contractile or relaxant effect on corpus cavernosum tissues. Both drugs caused a dose –dependent relaxation in tissues precontracted with phenylephrine. While the relaxant effect of atorvastatin is inhibited 40% by L-NAME, this relaxations are totally inhibited by atropine. The relaxations caused by gemfibrozil are inhibited both by L-NAME and atropine. No change was observed in responses of the tissues to acethylcholine, nitroprusside and electrical field stimulation when incubated with atorvastatin or gemfibrozil. As a conlusion, both drugs showed similar effects on corpus cavernosum tissues. Atorvastatin and gemfibrozil caused these effects via endothelial nitric oxide. When all the results are evaluated, not only the two drugs showed no unfavorable effects but also may have some beneficial effects on erectile functions.
- 24 June 2024
- Published by Springer Nature in Research Square
Open AccessEffects of Atorvastatin and Gemfibrozil on Mice Corpus Cavernosum, in vitro
Most of the drugs used in the treatment of cardiovascular diseases cause unfavourable effects on erectile functions. In this study, the effect of atorvastatin and gemfibrozil, which has different hypolipidemic mechanisms of action, on the erectile functions observed in mouse corpus cavernosum tissues are evaluatedin vitro. Mouse corpus cavernosum tissues are dissected under ketamine and xylazine anesthesia. Vessels were suspended in 30 ml organ baths filled with Krebs solution and aerated with carbogen (95% O2, 5% CO2) at 37°C. A initial tension of 500 mg was applied to the suspended tissue strips. After a stabilisation period of 90 minutes, the protocols were applied to the tissue. Atorvastatin and gemfibrozil showed no direct contractile or relaxant effect on corpus cavernosum tissues. Both drugs caused a dose –dependent relaxation in tissues precontracted with phenylephrine. While the relaxant effect of atorvastatin is inhibited 40% by L-NAME, this relaxations are totally inhibited by atropine. The relaxations caused by gemfibrozil are inhibited both by L-NAME and atropine. No change was observed in responses of the tissues to acethylcholine, nitroprusside and electrical field stimulation when incubated with atorvastatin or gemfibrozil. As a conlusion, both drugs showed similar effects on corpus cavernosum tissues. Atorvastatin and gemfibrozil caused these effects via endothelial nitric oxide. When all the results are evaluated, not only the two drugs showed no unfavorable effects but also may have some beneficial effects on erectile functions.
- Open Access
- 30 May 2024
- Published by New Trends in Medicine Sciences in New Trends in Medicine Sciences
- Vol. 5 (2) , 84-90
The Toxic Effects on the Testis of Flutamide vs. Bicalutamide vs. Cyproterone Acetate: An Experimental Rat Study
The aim of this study was to investigate the toxic effects on the rat testis of flutamide, bicalutamide, and cyproterone acetate using histopathological methods. Twenty-four male Sprague-Dawley rats were randomly divided into four groups, control (Group 1), flutamide (Group 2), bicalutamide (Group 3), and cyproterone acetate (Group 4). Physiological saline solution or anti-androgens were administered via oral gavage for 14 days. At the end of the study, the testes were harvested for histological toxic effect scoring. The mean histopathology scores were 0 in Group 1, 0.33 ± 0.81 in Group 2, 1.66 ± 1.36 in Group 3, and 2.93 ± 0.98 in Group 4. The histopathology score in Group 4 was significantly higher than that in Group 1 (p = 0.002), but was not significantly different to those in groups 2 and 3 (p = 0.317 and p = 0.028, respectively). No significant difference was also observed between the other groups. Cyproterone acetate, a steroidal antiandrogen, resulted in significant impairment of testis histology relative to the non-steroidal antiandrogens flutamide and bicalutamide. A non-steroidal agent such as flutamide or bicalutamide should therefore be selected if antiandrogen therapy is to be initiated for reasons such as acne, hirsutism, and paraphilias, particularly in young males.
- 30 May 2024
- Published by New Trends in Medicine Sciences in New Trends in Medicine Sciences
- Vol. 5 (2) , 84-90
Open AccessThe Toxic Effects on the Testis of Flutamide vs. Bicalutamide vs. Cyproterone Acetate: An Experimental Rat Study
The aim of this study was to investigate the toxic effects on the rat testis of flutamide, bicalutamide, and cyproterone acetate using histopathological methods. Twenty-four male Sprague-Dawley rats were randomly divided into four groups, control (Group 1), flutamide (Group 2), bicalutamide (Group 3), and cyproterone acetate (Group 4). Physiological saline solution or anti-androgens were administered via oral gavage for 14 days. At the end of the study, the testes were harvested for histological toxic effect scoring. The mean histopathology scores were 0 in Group 1, 0.33 ± 0.81 in Group 2, 1.66 ± 1.36 in Group 3, and 2.93 ± 0.98 in Group 4. The histopathology score in Group 4 was significantly higher than that in Group 1 (p = 0.002), but was not significantly different to those in groups 2 and 3 (p = 0.317 and p = 0.028, respectively). No significant difference was also observed between the other groups. Cyproterone acetate, a steroidal antiandrogen, resulted in significant impairment of testis histology relative to the non-steroidal antiandrogens flutamide and bicalutamide. A non-steroidal agent such as flutamide or bicalutamide should therefore be selected if antiandrogen therapy is to be initiated for reasons such as acne, hirsutism, and paraphilias, particularly in young males.
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 16-17
The Outcomes of Tianeptine in Pregnancy
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 16-17
The Outcomes of Tianeptine in Pregnancy
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 16
The Outcomes of Mesalamine Exposure in Pregnancy
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 16
The Outcomes of Mesalamine Exposure in Pregnancy
- 1 September 2019
- Published by Elsevier in Reproductive Toxicology
- Vol. 88, 145
#37 Mirtazapine exposure in pregnancy and four congenital anomalies among 59 cases
- 1 September 2019
- Published by Elsevier in Reproductive Toxicology
- Vol. 88, 145
#37 Mirtazapine exposure in pregnancy and four congenital anomalies among 59 cases
- 1 September 2019
- Published by Elsevier in Reproductive Toxicology
- Vol. 88, 144-145
#36 Gadolinium-based contrast agents in pregnant women
- 1 September 2019
- Published by Elsevier in Reproductive Toxicology
- Vol. 88, 144-145
#36 Gadolinium-based contrast agents in pregnant women
- 4 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152
The use of passiflora incarnate in pregnant women
- 4 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152
The use of passiflora incarnate in pregnant women
- 1 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152-153
Pseudoephedrine use in the first trimester
- 1 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152-153
Pseudoephedrine use in the first trimester